Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors
{{output}}
Purpose of review: Small molecule kinase inhibitors (SMKIs) have revolutionized the management of malignant and autoimmune disorders. Emerging clinical reports point toward an increased risk for invasive fungal infections (IFIs) ... ...
